XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ 336 $ (31,761)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 11,261 13,821
Amortization of intangible assets 3,356 4,192
Reduction in carrying amount of right-of-use asset 7,386 8,834
Provision for credit losses 85 1,770
Share-based compensation 61,573 58,709
Deferred income taxes (879) (153)
Provision for excess and obsolete inventory [1] 1,616 24,543
Non-cash interest expense 902 795
Other 703 (3,225)
Changes in operating assets and liabilities:    
Accounts receivable, net (10,113) 85,837
Inventories [1] 14,445 (122,132)
Prepaid expenses and other assets (20,331) (13,855)
Accounts payable (3,982) (17,340)
Accrued compensation and benefits 1,302 (27,252)
Operating lease liabilities (8,060) (8,780)
Deferred revenue 17,746 59,301
Other current and long-term liabilities (7,254) 6,693
Net cash provided by operating activities 70,092 39,997
Cash flows from investing activities:    
Capital expenditures (18,067) (13,632)
Net cash used in investing activities (18,067) (13,632)
Cash flows from financing activities:    
Net payments on revolving facility   (25,000)
Payments on debt obligations (7,500) (7,500)
Payments on debt financing costs (695)  
Repurchase of common stock (13,000) (49,855)
Payments for tax withholdings, net of proceeds from issuance of common stock (1,907) (27,564)
Net cash used in financing activities (23,102) (109,919)
Foreign currency effect on cash and cash equivalents (142) (265)
Net increase (decrease) in cash and cash equivalents 28,781 (83,819)
Cash and cash equivalents at beginning of period 156,699 234,826
Cash and cash equivalents at end of period $ 185,480 $ 151,007
[1] The prior period amounts have been reclassified to conform to the current period presentation